Description: TECHNE Corporation develops, manufactures, and sells biotechnology research and diagnostic products, and hematology calibrators and controls worldwide. The company's Biotechnology segment offers proteins, such as cytokines, and enzyme substrates and inhibitors; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits for the detection of human and animal proteins, and immunoassays that allow researchers to quantify a specific analyte in a biological fluids sample; clinical diagnostic immunoassay kits consisting of erythropoietin, transferrin receptor, and beta2-microglobulin immunoassays for use as in vitro diagnostic devices; flow cytometry products, such as fluorochrome labeled antibodies and kits; intracellular cell signaling products, including antibodies, phospho-specific antibodies, antibody arrays, active caspases, kinases, phosphatases, and enzyme-linked immunosorbant assays to measure the activity of apoptotic and signaling molecules; and natural and synthetic chemical compounds for use as agonists, antagonists, and inhibitors of various biological functions by investigators. Its Hematology segment provides a range of hematology controls and calibrators for impedance and laser type cell counters; and hematology control products for use as proficiency testing tools by laboratory certifying authorities. The company was founded in 1976 and is headquartered in Minneapolis, Minnesota.
Home Page: www.bio-techne.com
TECH Technical Analysis
614 McKinley Place N.E.
Minneapolis,
MN
55413
United States
Phone:
612 379 8854
Officers
| Name | Title |
|---|---|
| Mr. Charles R. Kummeth | CEO, Pres & Director |
| Mr. James T. Hippel | Exec. VP of Fin. & CFO |
| Ms. Brenda S. Furlow J.D. | Exec. VP, Gen. Counsel, Sec. & Chief Compliance Officer |
| Mr. Kim Kelderman | Pres of Diagnostics & Genomics |
| Mr. William A. Geist | Pres of Protein Sciences Segment |
| David Clair | Sr. Director of Investor Relations & Corp. Devel. |
| Mr. Gerry Andros | VP of Sales and Marketing |
| Mr. Robert M. Gavin | VP of Corp. Devel. |
| Ms. Brenda S. Everson | Sr. VP & Chief HR Officer |
| Mr. Luca Cicchetti | Managing Director |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Life Sciences Tools & Services |
| GIC Sub-Industry: | Life Sciences Tools & Services |
| Forward PE: | 42.1941 |
|---|---|
| Trailing PE: | 48.3464 |
| Price-to-Book MRQ: | 7.7815 |
| Price-to-Sales TTM: | 11.8254 |
| IPO Date: | 1989-02-09 |
| Fiscal Year End: | June |
| Full Time Employees: | 3000 |